Stereotactic Radiotherapy for Brain Metastases: A Detailed Overview of Indications, Dose Fractionation, Technological Advances, and Emerging Combination Therapies - Top-Institutions - MDSpire

Stereotactic Radiotherapy for Brain Metastases: A Detailed Overview of Indications, Dose Fractionation, Technological Advances, and Emerging Combination Therapies

  • By

  • Hu Chen

  • Shuai Li

  • Qiuyu Yang

  • Fangzheng Zhou

  • April 23, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Radiation Oncology
    • Neuro-Oncology
    • Medical Oncology

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Radiation Oncology
    • Neuro-Oncology
    • Medical Oncology

  • #3

    Dana-Farber/Brigham and Women’s Cancer Center
    Dana-Farber/Brigham and Women’s Cancer Center

    Boston, MA

    Key Differentiators

    • Radiation Oncology
    • Neuro-Oncology
    • Medical Oncology

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Radiation Oncology
    • Neuro-Oncology
    • Medical Oncology

  • #5

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Radiation Oncology
    • Neuro-Oncology
    • Medical Oncology

Original Source(s)

Stereotactic Radiotherapy for Brain Metastases: A Detailed Overview of Indications, Dose Fractionation, Technological Advances, and Emerging Combination Therapies

  • by Hu Chen, Shuai Li, Qiuyu Yang, Fangzheng Zhou

  • April 23, 2026

Related Content

Outcomes of critically ill pediatric patients after haploidentical stem cell transplantation

Recurrent pleuropulmonary blastoma type III initially misclassified as embryonal rhabdomyosarcoma on limited biopsy: a case report with pathogenic DICER1 variant

Data requirements of an informative, directive, and preventive mobile health application for gastric cancer